Nu Skin Enterprises

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of personal care products and nutritional supplements. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, Grow Tech, and Rhyz Other. The first seven segments represent the Nu Skin geographic operations. The last three segments deal with Rhyz investments. Its brands include Nu Skin and Pharmanex. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Nu Skin Enterprises reports $2.23B revenue for 2022, focuses on innovation and social commerce

Nu Skin Enterprises navigated challenges in 2022, focusing on innovation and social commerce to drive revenue growth. The company aims to overcome challenges in 2023 and achieve Nu Vision 2025 goals through strategic initiatives. Nu Skin's emphasis on enhancing the iO experience and optimizing expenses positions it for sustainable value to investors.

Nu Skin Enterprises meets Q1 expectations, eyes growth in Asia

Nu Skin's Q1 performance in line with expectations, with notable success in key markets like South Korea and Mainland China.
Challenges persist in certain regions due to macroeconomic factors, necessitating strategic adjustments for sustained growth.
Opportunities lie in expanding TRMe program, leveraging digital initiatives, and driving operational improvements for long-term value creation.

Nu Skin reports robust Q2 earnings, eyes growth through acquisitions

Nu Skin Enterprises delivered strong Q2 results driven by Mainland China growth, with revenue of $500.3 million and EPS of $0.54. The company faces challenges in other markets due to macro-related pressures.
Strategic acquisitions of BeautyBio and LifeDNA aim to enhance Nu Skin's core business through personalization and technology. The company's focus on innovation and market trends presents growth opportunities.
With a clear strategic direction, Nu Skin is poised to navigate challenges, capitalize on opportunities, and drive continued growth in the beauty and wellness industry.

Nu Skin reports Q3 revenue of $499M, adjusts 2023 guidance

Nu Skin adjusts 2023 guidance, expecting revenue of $1.92B to $1.96B and EPS of negative $0.10 to $0.05. The company is streamlining expenses and maximizing cash flow.

Nu Skin surpasses Q4 revenue targets, eyes growth opportunities

Nu Skin Enterprises delivered strong Q4 results, exceeding revenue guidance and showcasing a focus on innovation and strategic growth initiatives.
Despite challenges in certain regions, the company demonstrated resilience and stability in key markets, laying the groundwork for future expansion and market penetration.
By rebalancing dividends for growth investments and prioritizing reinvestment in the business, Nu Skin is poised to capitalize on opportunities for market diversification and sustainable growth.
With a clear roadmap for 2024, including product launches, market entries, and capital reallocation strategies, Nu Skin is well-positioned to drive performance and enhance shareholder value.

Nu Skin Enterprises reports robust Q1 earnings, eyes global expansion

Nu Skin Enterprises showcased resilience in revenue and earnings, driven by strong performance in core and new business segments.
While facing challenges from macroeconomic factors, the company is strategically focused on innovation, cost efficiency, and market expansion.
Opportunities lie in product diversification, market entries, and sustainability efforts, positioning Nu Skin for future growth and market leadership.

Nu Skin surpasses Q2 revenue targets, eyes growth amid challenges

Nu Skin Enterprises delivered strong Q2 performance, exceeding revenue guidance and showcasing financial discipline. Despite challenges in China and FX pressures, the company remains focused on innovation and growth. Strategic investments in new products, markets, and brand awareness position Nu Skin for future success. Revised guidance reflects adaptability to market conditions and commitment to long-term vision.

Nu Skin Enterprises meets Q3 guidance, eyes India expansion

Nu Skin's Q3 performance reflects a balanced approach to addressing challenges and leveraging strengths.
Strategic initiatives to drive growth, optimize operations, and expand into new markets are key focus areas.
Despite market pressures, Nu Skin's focus on innovation and efficiency bodes well for future growth.
Overall, Nu Skin's financials and strategic direction indicate a resilient and forward-thinking company.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of beauty and wellness solutions. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, and Rhyz Other. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock?

Nu Skin (NUS) Up 11.9% Since Last Earnings Report: Can It Continue?

Nu Skin (NUS) has been seeing improved trends in Mainland China as coronavirus-induced restrictions are being lifted in the region.

Here's Why Nu Skin (NUS) Stock is Up More Than 40% in a Month

As of late, it has definitely been a great time to be an investor in Nu Skin Enterprises

Nu Skin Enterprises' Shares March Higher, Can It Continue?

NUS vs. PORBF: Which Stock Is the Better Value Option?

Coty

Estee Lauder

Cosmetics Industry Outlook Prospects Dimmed by Coronavirus Woes

Both Q1 results and 2020 guidance came in significantly higher than analyst estimates.

Why Nu Skin Enterprises Blasted Nearly 30% Higher on Thursday

Why Nu Skin Enterprises Blasted Nearly 30% Higher on Thursday (NUS)

Nu Skin's (NUS) first-quarter 2020 results reflect lower earnings and sales. Foreign currency headwinds and reduced sales leaders in Mainland China hurt results.

Nu Skin's (NUS) Q1 Earnings Beat Estimates, Decline Y/Y

Nu Skin Enterprises, Inc. (NUS) CEO Ritch Wood on Q1 2020 Results - Earnings Call Transcript

Nu Skin (NUS) delivered earnings and revenue surprises of 50.00% and 6.90%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Nu Skin Enterprises (NUS) Surpasses Q1 Earnings and Revenue Estimates

Multi-level marketing company Nu Skin Enterprises Inc. NUS, +0.36% shares rose nearly 8% in the extended session Wednesday, after the company beat earnings and revenue expectations.

Nu Skin stock rises after earnings beat

Impacts from foreign currency headwinds are likely to get reflected on Nu Skin's (NUS) first-quarter 2020 results. Also, restrictions on travel amid coronavirus are a concern.

Here's How Nu Skin (NUS) is Placed Ahead of Q1 Earnings

AbbVie

Bunge Global SA

Chevron

DXC Technology

Patterson Companies

Steep market declines in 2020 have not only been brutal on returns; they've also presented income investors with a conundrum.

8 Safe High-Yield Dividend Stocks Offering 5% or More

Why Is Nu Skin (NUS) Down 37.4% Since Last Earnings Report?

Nu Skin (NUS) anticipates sales in Mainland China to decline 20-25% in 2020. The company puts meetings on hold in the region due to the coronavirus outbreak.

Will Nu Skin Mainland China Woes Worsen Due to Coronavirus?

In trading on Thursday, shares of NU Skin Enterprises, Inc. (NYSE:NUS) were yielding above the 6% mark based on its quarterly dividend (annualized to $1.5), with the stock changing hands as low as $24.34 on the day.

NU Skin Enterprises Breaks Above 6% Yield Territory

Inter Parfums

Coronavirus-led worries weigh on the guidance of these cosmetic stocks due to reduced global travel and sluggish traffic.

Coronavirus Steals Glitter Off These 3 Cosmetic Stocks

The coronavirus outbreak in China is badly hurting the maker of personal care products.

Why Nu Skin Enterprises Stock Fell Today

Nu Skin's (NUS) fourth-quarter 2019 results reflect lower earnings and sales. Further, management expects the coronavirus outbreak to hurt Mainland China sales in 2020.

Nu Skin's (NUS) Q4 Earnings Meet Estimates, Down Year on Year

Nu Skin Enterprises, Inc. (NUS) CEO Ritch Wood on Q4 2019 Results - Earnings Call Transcript

Nu Skin (NUS) delivered earnings and revenue surprises of 0.00% and 0.02%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Nu Skin Enterprises (NUS) Q4 Earnings Match Estimates

Nu Skin Enterprises Inc. NUS, +3.38% shares dropped in the extended session Wednesday after the maker of supplements and personal care products blamed its disappointing outlook on sales in China due to the COVAD-19 coronavirus.

Nu Skin stock drops more than 10% on China profit warning

Impacts from foreign currency headwinds are likely to get reflected in Nu Skin's (NUS) fourth-quarter 2019 results. However, the company is on track with product launches and programs to bolster sales leaders.

Here's How Nu Skin (NUS) is Placed Ahead of Q4 Earnings

Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Nu Skin Enterprises (NUS) Q4 Earnings Expected to Decline

If You're OK With Taking On Regulatory Risks, Nu Skin Might Be Right For You

News for Nu Skin Enterprises Stock (NUS)